Cancer is among the chronic diseases that have been claiming many lives across the world. The disease is known to attack people from all walks of lives, and there are few cases of survival. Scientists have been trying to find a lasting solution to combating the disease, but few scientific gains have been achieved. Mikhail Blagosklonny is a well recognized Professor of Oncology from the Roswell Park Cancer Institute. He has been carrying out research with the aim of finding how cancer affects the aging generation. Studies have revealed that older people are prone to cancer as compared to younger people. As such, Mikhail Blagosklonny examines the relationship of this two factors and how they can be managed to reduce fatalities. He also holds a Master’s Degree in Internal Medicine from the First Pavlov State Medical University of St. Petersburg and Ph.D. in Experimental Medicine respectively from the same university. He has vast experience in Biogerontology that has enabled him to find a solution to guarding the healthy cells against being damaged during the aging period. He has also developed drugs that have been used in the treatment process of anti-aging cells and therapies that have changed the lives of many cancer patients. Read more on

Mikhail Blagosklonny possesses vast knowledge in medical research and has published many medical research materials. The materials have been used widely by medical students from different parts of the world. This experience has earned him a position as the editor-in-chief of Oncotarget and Cell Cycle. He also holds a position of an associate editor of cancer biology and therapy. This tremendous success has been pegged on his educational background and the passion for helping save lives. He is also a member of the Cell Death and Differentiation editorial board. His numerous achievements have made him be recognized as the passionate advocate of Rapamycin.

Mikhail Blagosklonny has also authored hyperfunction theory that speaks about aging and how to tackle the situation during old age. He has also published over 300 articles, book and reviews about cancer and aging with a keen focus on how to avert fatalities. He attributes his research in the field as a passion he developed at a younger age to see a disease-free nation. View his LinkedIn profile